CAPITOL COUNSEL LLC

Lobbying for EMD SERONO, INC. · Pharmaceutical manufacturing, research, and development.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $50,000.00 income · posted Oct 16, 2025

Lobbying activity 2

Medicare/Medicaid

Issues regarding the availability and pricing of prescription drugs.

Pharmacy

Issues regarding the availability and pricing of prescription drugs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.